References
References - curated
Region Position Markers
QTLs in Region (GRCh38)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 406938309 | GWAS587285_H | total cholesterol measurement QTL GWAS587285 (human) | 0.0000003 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58387469 | 58387470 | Human | 406984260 | GWAS633236_H | level of Sphingomyelin (d34:1) in blood serum QTL GWAS633236 (human) | 7e-11 | level of Sphingomyelin (d34:1) in blood serum | 15 | 58387469 | 58387470 | Human | 406938310 | GWAS587286_H | total cholesterol measurement QTL GWAS587286 (human) | 2e-28 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58387469 | 58387470 | Human | 406952910 | GWAS601886_H | total cholesterol measurement QTL GWAS601886 (human) | 4e-78 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58387469 | 58387470 | Human | 407102032 | GWAS751008_H | 1-linoleoyl-GPE (18:2) measurement QTL GWAS751008 (human) | 5e-18 | 1-linoleoyl-GPE (18:2) measurement | 15 | 58387469 | 58387470 | Human | 406962517 | GWAS611493_H | serum metabolite measurement QTL GWAS611493 (human) | 6e-28 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406952149 | GWAS601125_H | high density lipoprotein cholesterol measurement QTL GWAS601125 (human) | 4e-16 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58387469 | 58387470 | Human | 2299958 | PRSTS330_H | Prostate tumor susceptibility QTL 330 (human) | 1.02 | 0.0151 | Prostate tumor susceptibility | 15 | 34790230 | 60790230 | Human | 406903637 | GWAS552613_H | 1-docosahexaenoyl-GPE (22:6) measurement QTL GWAS552613 (human) | 2e-20 | 1-docosahexaenoyl-GPE (22:6) measurement | 15 | 58387469 | 58387470 | Human | 406952148 | GWAS601124_H | high density lipoprotein cholesterol measurement QTL GWAS601124 (human) | 0.0000001 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58387469 | 58387470 | Human | 406952151 | GWAS601127_H | high density lipoprotein cholesterol measurement QTL GWAS601127 (human) | 3e-124 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58387469 | 58387470 | Human | 406962518 | GWAS611494_H | serum metabolite measurement QTL GWAS611494 (human) | 1e-27 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406952150 | GWAS601126_H | high density lipoprotein cholesterol measurement QTL GWAS601126 (human) | 0.000004 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58387469 | 58387470 | Human | 406968281 | GWAS617257_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS617257 (human) | 2e-192 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58387469 | 58387470 | Human | 406968280 | GWAS617256_H | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS617256 (human) | 1e-248 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58387469 | 58387470 | Human | 406980958 | GWAS629934_H | serum metabolite measurement QTL GWAS629934 (human) | 1e-47 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406980966 | GWAS629942_H | serum metabolite measurement QTL GWAS629942 (human) | 3e-13 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406938853 | GWAS587829_H | triglyceride measurement QTL GWAS587829 (human) | 0.000003 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58387469 | 58387470 | Human | 406938852 | GWAS587828_H | triglyceride measurement QTL GWAS587828 (human) | 4e-13 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58387469 | 58387470 | Human | 406980970 | GWAS629946_H | serum metabolite measurement QTL GWAS629946 (human) | 1e-12 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406938856 | GWAS587832_H | triglyceride measurement QTL GWAS587832 (human) | 2e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58387469 | 58387470 | Human | 1559354 | LDLPS4_H | Low density lipoprotein particle size QTL 4 (human) | 2.2 | 0.019 | LDL particle size | 15 | 34790230 | 60790230 | Human | 407101681 | GWAS750657_H | 1-arachidonoyl-GPE (20:4n6) measurement QTL GWAS750657 (human) | 2e-27 | 1-arachidonoyl-GPE (20:4n6) measurement | 15 | 58387469 | 58387470 | Human | 406984183 | GWAS633159_H | level of Phosphatidylcholine (17:0_18:1) in blood serum QTL GWAS633159 (human) | 4e-11 | level of Phosphatidylcholine (17:0_18:1) in blood serum | 15 | 58387469 | 58387470 | Human | 406981115 | GWAS630091_H | serum metabolite measurement QTL GWAS630091 (human) | 5e-11 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406979960 | GWAS628936_H | hematocrit QTL GWAS628936 (human) | 1e-13 | hematocrit | hematocrit (CMO:0000037) | 15 | 58387469 | 58387470 | Human | 406961661 | GWAS610637_H | serum metabolite measurement QTL GWAS610637 (human) | 4e-30 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406961660 | GWAS610636_H | serum metabolite measurement QTL GWAS610636 (human) | 8e-35 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406962052 | GWAS611028_H | sphingomyelin measurement QTL GWAS611028 (human) | 2e-12 | sphingomyelin measurement | 15 | 58387469 | 58387470 | Human | 406938502 | GWAS587478_H | total cholesterol measurement QTL GWAS587478 (human) | 4e-22 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 15 | 58387469 | 58387470 | Human | 406961677 | GWAS610653_H | serum metabolite measurement QTL GWAS610653 (human) | 4e-19 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406961679 | GWAS610655_H | serum metabolite measurement QTL GWAS610655 (human) | 3e-18 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406962447 | GWAS611423_H | serum metabolite measurement QTL GWAS611423 (human) | 3e-12 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406961681 | GWAS610657_H | serum metabolite measurement QTL GWAS610657 (human) | 1e-10 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406961041 | GWAS610017_H | serum metabolite measurement QTL GWAS610017 (human) | 1e-25 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 407096980 | GWAS745956_H | triglycerides to total lipids in large VLDL percentage QTL GWAS745956 (human) | 8e-196 | triglycerides to total lipids in large VLDL percentage | 15 | 58387469 | 58387470 | Human | 406968730 | GWAS617706_H | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS617706 (human) | 5e-99 | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 15 | 58387469 | 58387470 | Human | 406961050 | GWAS610026_H | serum metabolite measurement QTL GWAS610026 (human) | 7e-32 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406981282 | GWAS630258_H | serum metabolite measurement QTL GWAS630258 (human) | 2e-85 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406981414 | GWAS630390_H | serum metabolite measurement QTL GWAS630390 (human) | 2e-10 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406961830 | GWAS610806_H | free cholesterol measurement, intermediate density lipoprotein measurement QTL GWAS610806 (human) | 9e-11 | free cholesterol measurement, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 15 | 58387469 | 58387470 | Human | 406952874 | GWAS601850_H | phosphatidylethanolamine measurement QTL GWAS601850 (human) | 4e-20 | phosphatidylethanolamine measurement | 15 | 58387469 | 58387470 | Human | 406952115 | GWAS601091_H | high density lipoprotein cholesterol measurement QTL GWAS601091 (human) | 6e-100 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 15 | 58387469 | 58387470 | Human | 406981424 | GWAS630400_H | serum metabolite measurement QTL GWAS630400 (human) | 0.0000004 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406981425 | GWAS630401_H | serum metabolite measurement QTL GWAS630401 (human) | 0.0000005 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406960567 | GWAS609543_H | serum metabolite measurement QTL GWAS609543 (human) | 2e-11 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406981556 | GWAS630532_H | serum metabolite measurement QTL GWAS630532 (human) | 8e-10 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406981557 | GWAS630533_H | serum metabolite measurement QTL GWAS630533 (human) | 9e-10 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406982453 | GWAS631429_H | triglyceride measurement QTL GWAS631429 (human) | 5e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 15 | 58387469 | 58387470 | Human | 406960568 | GWAS609544_H | serum metabolite measurement QTL GWAS609544 (human) | 2e-14 | serum metabolite measurement | 15 | 58387469 | 58387470 | Human | 406980792 | GWAS629768_H | triglyceride measurement, physical activity QTL GWAS629768 (human) | 1e-149 | triglyceride measurement, physical activity | blood triglyceride level (CMO:0000118) | 15 | 58387469 | 58387470 | Human | |
Additional Information
GWAS QTLs Related by Peak Marker
Data has come from the GWAS Catalog | ||
The highlighted row represents the current QTL |
QTL | GWAS Catalog Study | Disease Trait | Study Size | Risk Allele | Risk Allele Frequency | P Value | P Value MLOG | Peak Marker | Reported Odds Ratio or Beta-coefficient | Ontology Accession | PubMed |
GWAS552613_H | GCST90102681 | 1-docosahexaenoyl-GPE (22:6) levels | 8,809 European ancestry individuals | A | NR | 2E-20 | 19.699 | rs7350789 | 0.141 | 1-docosahexaenoyl-GPE (22:6) measurement (EFO:0800296) |
PMID:35050183 |
GWAS587285_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.64 | 3E-7 | 6.523 | rs7350789 | 0.085 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS587286_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | NR | 2E-28 | 27.699 | rs7350789 | 0.049 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS587478_H | GCST007143 | Total cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.654 | 4E-22 | 21.398 | rs7350789 | 0.047 | total cholesterol measurement (EFO:0004574) |
PMID:29507422 |
GWAS587828_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.654 | 4E-13 | 12.398 | rs7350789 | 0.032 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS587829_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.64 | 0.000003 | 5.523 | rs7350789 | 0.071 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS587832_H | GCST007142 | Triglycerides | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | NR | 2E-18 | 17.699 | rs7350789 | 0.035 | triglyceride measurement (EFO:0004530) |
PMID:29507422 |
GWAS601091_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.654 | 6E-100 | 99.222 | rs7350789 | 0.084 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS601124_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.676 | 1E-7 | 7 | rs7350789 | 0.071 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS601125_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.64 | 4E-16 | 15.398 | rs7350789 | 0.113 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS601126_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | 0.628 | 0.000004 | 5.398 | rs7350789 | 0.104 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS601127_H | GCST007140 | High density lipoprotein cholesterol levels | 76,627 European ancestry individuals, 7,795 Hispanic individuals, 6,855 East Asian ancestry individuals, 2,958 African American individuals, 439 South Asian ancestry individuals | G | NR | 3E-124 | 123.523 | rs7350789 | 0.085 | high density lipoprotein cholesterol measurement (EFO:0004612) |
PMID:29507422 |
GWAS601850_H | GCST008929 | Phosphatidylethanolamine levels | 2,045 European ancestry individuals | A | NR | 4E-20 | 19.398 | rs7350789 | 0.2979 | phosphatidylethanolamine measurement (EFO:0010228) |
PMID:31551469 |
GWAS601886_H | GCST006614 | Total cholesterol levels | 215,551 European ancestry individuals, 57,332 African American individuals, 24,743 Hispanic individuals | A | 0.3451 | 4E-78 | 77.398 | rs7350789 | 0.0522 | total cholesterol measurement (EFO:0004574) |
PMID:30275531 |
GWAS609543_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-11 | 10.699 | rs7350789 | 0.054938268 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS609544_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-14 | 13.699 | rs7350789 | 0.0702734 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610017_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-25 | 25 | rs7350789 | 0.11972121 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610026_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 7E-32 | 31.155 | rs7350789 | 0.10872544 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610636_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 8E-35 | 34.097 | rs7350789 | 0.10312867 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610637_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 4E-30 | 29.398 | rs7350789 | 0.09544789 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610653_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 4E-19 | 18.398 | rs7350789 | 0.13139343 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610655_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-18 | 17.523 | rs7350789 | 0.109545276 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS610657_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 1E-10 | 10 | rs7350789 | 0.09513239 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
None Available | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 2E-11 | 10.699 | rs7350789 | 0.08209028 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS611423_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-12 | 11.523 | rs7350789 | 0.08568997 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS611493_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 6E-28 | 27.222 | rs7350789 | 0.09362299 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS611494_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 1E-27 | 27 | rs7350789 | 0.08421296 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS617256_H | GCST90092879 | Triglycerides to total lipids ratio in large VLDL | 115,071 European ancestry individuals | G | 0.646053 | 1E-248 | 248 | rs7350789 | 0.144797 | triglycerides:total lipids ratio (EFO:0020947) very low density lipoprotein cholesterol measurement (EFO:0008317) |
PMID:35213538 |
GWAS617257_H | GCST90092877 | Phospholipids to total lipids ratio in large VLDL | 115,071 European ancestry individuals | G | 0.646053 | 2E-192 | 191.699 | rs7350789 | 0.124104 | very low density lipoprotein cholesterol measurement (EFO:0008317) phospholipids:total lipids ratio (EFO:0020946) |
PMID:35213538 |
GWAS617706_H | GCST90092873 | Free cholesterol to total lipids ratio in large VLDL | 115,071 European ancestry individuals | G | 0.646053 | 5E-99 | 98.302 | rs7350789 | 0.0904029 | very low density lipoprotein cholesterol measurement (EFO:0008317) free cholesterol:total lipids ratio (EFO:0020945) |
PMID:35213538 |
GWAS628936_H | GCST90002383 | Hematocrit | 408,112 British individuals | A | 0.354791 | 1E-13 | 13 | rs7350789 | 0.017170137 | hematocrit (EFO:0004348) |
PMID:32888494 |
GWAS629768_H | GCST007286 | Triglycerides x physical activity interaction (2df test) | 7,294 African American inactive individuals, 12,832 African American active individuals, 1,352 Asian ancestry inactive individuals, 3,049 Asian ancestry active individuals, 20,622 European ancestry inactive individuals, 51,480 European ancestry active individuals, 2,166 Hispanic or Latin American inactive individuals, 3,486 Hispanic or Latin American active individuals | A | 0.346 | 1E-149 | 149 | rs7350789 | N/A | triglyceride measurement (EFO:0004530) physical activity (EFO:0003940) |
PMID:30670697 |
GWAS629934_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 1E-47 | 47 | rs7350789 | 0.18179038 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS629942_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 3E-13 | 12.523 | rs7350789 | 0.09118287 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS629946_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 1E-12 | 12 | rs7350789 | 0.08727236 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630091_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 5E-11 | 10.302 | rs7350789 | 0.057159528 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630258_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-85 | 84.699 | rs7350789 | 0.1738073 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630390_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 2E-10 | 9.699 | rs7350789 | 0.0665491 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630400_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 4E-7 | 6.398 | rs7350789 | 0.064160354 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630401_H | GCST009242 | Serum metabolite levels | 6,263 Finnish ancestry men | ? | NR | 5E-7 | 6.302 | rs7350789 | 0.061311882 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630532_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 8E-10 | 9.097 | rs7350789 | 0.06674564 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS630533_H | GCST009240 | Serum metabolite levels (CMS) | 6,263 Finnish ancestry men | ? | NR | 9E-10 | 9.046 | rs7350789 | 0.05438878 | serum metabolite measurement (EFO:0005653) |
PMID:31636271 |
GWAS631429_H | GCST011050 | Postprandial triglyceride response | 5,630 individuals | A | 0.36 | 5E-8 | 7.302 | rs7350789 | 0.11 | triglyceride measurement (EFO:0004530) |
PMID:32603185 |
GWAS633159_H | GCST90277296 | Phosphatidylcholine (17:0_18:1) levels | 7,073 Finnish ancestry individuals | A | 0.39282 | 4E-11 | 10.398 | rs7350789 | 0.112631 | PMID:37907536 | |
GWAS633236_H | GCST90277370 | Sphingomyelin (d34:1) levels | 7,174 Finnish ancestry individuals | A | 0.39282 | 7E-11 | 10.155 | rs7350789 | 0.110435 | PMID:37907536 | |
GWAS745956_H | GCST90269690 | Triglycerides to total lipids in large VLDL percentage (UKB data field 23593) | 88,321 European ancestry individuals | A | 0.353893 | 8E-196 | 195.097 | rs7350789 | 0.147002 | triglycerides to total lipids in large VLDL percentage (EFO:0022332) |
PMID:36764567 |
GWAS750657_H | GCST90299542 | Metabolite levels (1-arachidonoylglycerophosphoethanolamine; 1-arachidonoyl-GPE (20:4n6); C20:4 LPE; C20_4_LPE) | 11,272 European, Hispanic or African American individuals | A | 0.3399 | 2E-27 | 26.699 | rs7350789 | 0.154 | 1-arachidonoyl-GPE (20:4n6) measurement (EFO:0800248) |
PMID:37253714 |
GWAS751008_H | GCST90299688 | Metabolite levels (1-linoleoylglycerophosphoethanolamine; 1-linoleoyl-GPE (18:2); C18:2 LPE; C18_2_LPE) | 11,268 European, Hispanic or African American individuals | A | 0.3399 | 5E-18 | 17.302 | rs7350789 | 0.123 | 1-linoleoyl-GPE (18:2) measurement (EFO:0800247) |
PMID:37253714 |
None Available | GCST90091604 | Fasting sphingomyelins | null | A | 0.355478417 | 2E-12 | 11.699 | rs7350789 | 0.150708 | sphingomyelin measurement (EFO:0010118) |
PMID:34610981 |
None Available | GCST90091669 | Postprandial free cholesterol in IDL | null | A | 0.357569489 | 9E-11 | 10.046 | rs7350789 | 0.143914 | free cholesterol measurement (EFO:0008591) intermediate density lipoprotein measurement (EFO:0008595) |
PMID:34610981 |
RGD Curation Notes
Note Type | Note | Reference |
---|